发明名称 |
DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1 |
摘要 |
In-vitro diagnosis and/or risk classification of heart diseases and/or diseases of the lung and respiratory tract, comprises carrying out a determination of the free fragments N-terminal pro-endothelin-1 (NT-proET-1) (18-52) or their fragments and partial peptides, in a patient to be examined. Independent claims are included for: (1) a kit for the diagnosis and/or risk classification of heart diseases and/or diseases of the lung and respiratory tract, comprising verification reagents for the determination of the free fragments NT-proET-1 or their fragments and partial peptides, and optionally further markers and auxiliary materials; and (2) a diagnostic device for performing the method. ACTIVITY : Cardiant; Respiratory-Gen. MECHANISM OF ACTION : None given. |
申请公布号 |
EP2147316(A2) |
申请公布日期 |
2010.01.27 |
申请号 |
EP20080758039 |
申请日期 |
2008.05.08 |
申请人 |
BRAHMS AKTIENGESELLSCHAFT |
发明人 |
BERGMANN, ANDREAS;STRUCK, JOACHIM |
分类号 |
G01N33/74 |
主分类号 |
G01N33/74 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|